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Purpose

Conclusion

To investigate dosimetric effect of tumor tracking. To evaluate
changes of treatment volumes when tracking is applied.

Implementation of real-time tracking techniques can minimize
irradiation to healthy tissues and improve sparing of critical organs.
Consequently, quality of patient treatment potentially can be
improved.

Method and Materials
Tumors in thorax region incur significant amount of motion and
deformation due to respiratory and cardiac cycles. In this study,
volumetric and dosimetric effect of tumor motion tracking have
been investigated. We have analyzed data for ten patients who were
diagnosed with lung cancer. In order to make dosimetry comparison,
the treatment plan was made for each of ten phases of tumor motion.
The dosimetric and volumetric effects were analyzed for two groups
of tumor motion. In the first group tumor motion was up to 1.5cm,
whereas for the second the motion was up to 2.5cm.

Results
It was observed that during respiratory cycle GTV was changed from
1-3cm3 for GTVs around 20cm3, 5cm3 for GTVs around 50cm3, and
20cm3 for GTVs of 100 cm3 and above, depending on tumor position
and respiratory cycle itself. When active tracking was applied and
tumor motion was up to 1.5 cm, irradiated PTV was from 20-30%
less for medium size tumors and more than 50% for small size
tumors. For tumor motion range up to 2.5cm, irradiated PTV was
two times smaller when tracking is applied. It was noticed that V20
with tracking was from 2-15% less of V20 without tracking, for tumor
motion up to 1.5cm. For tumors within motion range from 2.2cm
to 2.5cm, V20 with tracking was from 11-30% less comparing to
one without tracking. Calculating dose it was concluded that 20%
of healthy lung approximately receives from 2Gy to 6Gy less when
tumor tracking technique was used.
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